v3.26.1
Debt - Narrative (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
Mar. 18, 2026
USD ($)
$ / shares
shares
Nov. 17, 2025
USD ($)
$ / shares
shares
Jan. 13, 2025
USD ($)
$ / shares
Jul. 31, 2024
Jun. 30, 2026
USD ($)
shares
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
shares
Jun. 30, 2025
USD ($)
Feb. 29, 2024
$ / shares
shares
Dec. 31, 2022
Dec. 16, 2022
USD ($)
Debt Instrument [Line Items]                      
Interest rate, basis spread (greater of)       2.00%              
Loss on debt extinguishment         $ 0 $ 0 $ 0 $ 681      
K2 Healthventures LLC                      
Debt Instrument [Line Items]                      
Sale of stock conversion of outstanding loan $ 1,000 $ 4,000                  
Sale of stock, price per share (in dollars per share) | $ / shares $ 4.83 $ 4.83                  
Stock issued during period (in shares) | shares 207,215 828,860                  
Expected term                      
Debt Instrument [Line Items]                      
Warrants, expected life         10 years   10 years        
Risk free interest rate                      
Debt Instrument [Line Items]                      
Warrants, measurement input         0.0479   0.0479        
Price volatility                      
Debt Instrument [Line Items]                      
Warrants, measurement input         0.8947   0.8947        
K2 Warrants                      
Debt Instrument [Line Items]                      
Number of shares called by warrants, multiplier                   0.0375  
K2 Warrants | Common Stock                      
Debt Instrument [Line Items]                      
Number of warrants or rights outstanding (in shares) | shares                 35,773    
New Warrant | Common Stock                      
Debt Instrument [Line Items]                      
Number of shares called by warrants (in shares) | shares         134,691   134,691        
Fair value of warrants         $ 500   $ 500        
Loan and Security Agreement                      
Debt Instrument [Line Items]                      
Extinguishment of debt, amount     $ 10,000                
Loan and Security Agreement | Secured Debt                      
Debt Instrument [Line Items]                      
Aggregate principle amount (up to)                     $ 35,000
Final fee, percent of loan funded                     6.25%
One-time facility fee                     $ 200
Prepayment fee, percent of outstanding principal, applicable on or before 24 months after initial funding date     3.00%                
Prepayment fee, percent of outstanding principal, applicable on or before 36 months after initial funding date     2.00%                
Prepayment fee, percent of outstanding principal, applicable 36 months after initial funding date     1.00%                
Interest rate increase in event of default                     5.00%
Conversion price per share | $ / shares     $ 4.83           $ 10.49    
Weighted average interest rate         12.22% 12.96% 12.28% 12.96%      
Interest expense         $ 500 $ 600 $ 1,000 $ 1,200      
Loan and Security Agreement | Secured Debt | Maximum                      
Debt Instrument [Line Items]                      
Amount of debt convertible to equity at election of lender     $ 5,000               $ 4,000
Amount of debt convertible to equity at election of lender     5,000                
Loan and Security Agreement | Secured Debt | Fourth tranche, available through January 1, 2025                      
Debt Instrument [Line Items]                      
Aggregate principle amount (up to)                     10,000
Loan and Security Agreement | Secured Debt | First tranche, funded on December 16, 2022                      
Debt Instrument [Line Items]                      
Exit Fee                     $ 600
Amended Loan Agreement                      
Debt Instrument [Line Items]                      
Exit Fee         1,815   1,815        
Amended Loan Agreement | Secured Debt                      
Debt Instrument [Line Items]                      
Term loan     $ 75,000                
Interest rate, basis spread (greater of)     1.45%                
Interest rate floor     8.45%                
Fixed rate, paid-in-kind     1.00%                
Final payment, percentage of amount borrowed     5.95%                
Debt issuance costs and discount           $ 2,000   2,000      
Loss on debt extinguishment               $ 700      
One-time facility fee     $ 300                
Exit Fee         $ 1,200   $ 1,200        
Minimum number of months of cash runway     5 months                
Minimum market capitalization     $ 700,000                
Conversion price per share | $ / shares     $ 3.71                
Number of shares called by warrants, multiplier     0.025                
Sale of stock, price per share (in dollars per share) | $ / shares $ 4.83 $ 4.83                  
Amended Loan Agreement | Secured Debt | Maximum                      
Debt Instrument [Line Items]                      
Amount of debt convertible to equity at election of lender     $ 9,000                
Amended Loan Agreement | Secured Debt | First tranche, funded on December 16, 2022                      
Debt Instrument [Line Items]                      
Term loan     20,000                
Proceeds from issuance of debt     20,000                
Amended Loan Agreement | Secured Debt | Second tranche, available between October 1, 2023 and March 1, 2024                      
Debt Instrument [Line Items]                      
Term loan     30,000                
Amended Loan Agreement | Secured Debt | Third tranche, available from October 1, 2023 and March 1, 2024                      
Debt Instrument [Line Items]                      
Term loan     $ 25,000                
Funding fee multiplier     0.005